• 1
    Chambers MS, Rosenthal DI, Weber RS. Radiation-induced xerostomia. Head Neck. 2007; 29: 58-63.
  • 2
    Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand. 1967; 25( suppl 49): 41-126.
  • 3
    Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21: 109-122.
  • 4
    Chambers MS, Toth BB, Martin JW, Fleming TJ, Lemon JC. Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer. 1995; 3: 168-175.
  • 5
    Chambers MS. Clinical commentary on prophylactic treatment of radiation-induced xerostomia. Arch Otolaryngol Head Neck Surg. 2003; 129: 251-252.
  • 6
    Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope. 2010; 120: 2218-2222.
  • 7
    Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006; 24: 2618-2623.
  • 8
    Pacholke HD, Amdur RJ, Louis DA, Yang H, Mendenhall WM. The role of intensity modulated radiation therapy for favorable stage tumor of the nasal cavity or ethmoid sinus. Am J Clin Oncol. 2005; 28: 474-478.
  • 9
    Pacholke HD, Amdur RJ, Morris CG, et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol. 2005; 28: 351-358.
  • 10
    Eisbruch A, Rhodus N, Rosenthal D, et al. The prevention and treatment of radiotherapy-induced xerostomia. Semin Radiat Oncol. 2003; 13: 302-308.
  • 11
    Amosson CM, Teh BS, Van TJ, et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys. 2003; 56: 136-144.
  • 12
    Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 695-704.
  • 13
    Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 1999; 45: 577-587.
  • 14
    Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006; 66: 981-991.
  • 15
    Chao KS, Majhail N, Huang CJ, et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001; 61: 275-280.
  • 16
    Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002; 53: 12-22.
  • 17
    Garcia MK, Chiang JS, Cohen L, et al. Acupuncture for radiation-induced xerostomia in patients with cancer: a pilot study. Head Neck. 2009; 31: 1360-1368.
  • 18
    Fox PC, Van der Ven PF, Baum BJ, Mandel ID. Pilocarpine for the treatment of xerostomia associated with salivary gland dysfunction. Oral Surg Oral Med Oral Pathol. 1986; 61: 243-248.
  • 19
    Greenspan D, Daniels TE. Effectiveness of pilocarpine in postradiation xerostomia. Cancer. 1987; 59: 1123-1125.
  • 20
    Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993; 329: 390-395.
  • 21
    Zimmerman RP, Mark RJ, Tran LM, Juillard GF. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys. 1997; 37: 571-575.
  • 22
    Horiot JC, Lipinski F, Schraub S, et al. Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study. Radiother Oncol. 2000; 55: 233-239.
  • 23
    Brizel DM, Wasserman TH, Henke M, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 2000; 18: 3339-3345.
  • 24
    Rudat V, Meyer J, Momm F, et al. Protective effect of amifostine on dental health after radiotherapy of the head and neck. Int J Radiat Oncol Biol Phys. 2000; 48: 1339-1343.
  • 25
    Wasserman T, Mackowiak JI, Brizel DM, et al. Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys. 2000; 48: 1035-1039.
  • 26
    Lindegaard JC, Grau C. Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol. 2000; 57: 113-118.
  • 27
    Jha N, Seikaly H, Harris J, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck. 2009; 31: 234-243.
  • 28
    Weiss WW Jr, Brenman HS, Katz P, Bennett JA. Use of an electronic stimulator for the treatment of dry mouth. J Oral Maxillofac Surg. 1986; 44: 845-850.
  • 29
    Steller M, Chou L, Daniels TE. Electrical stimulation of salivary flow in patients with Sjogren's syndrome. J Dent Res. 1988; 67: 1334-1337.
  • 30
    Fontanesi J, Golden EB, Cianci P. Hyperbaric oxygen therapy can reverse radiation-induced xerostomia. J Hyperbaric Med. 1991; 6: 215-221.
  • 31
    Rydholm M, Strang P. Acupuncture for patients in hospital-based home care suffering from xerostomia. J Palliat Care. 1999; 15: 20-23.
  • 32
    Blom M, Lundeberg T. Long-term follow-up of patients treated with acupuncture for xerostomia and the influence of additional treatment. Oral Dis. 2000; 6: 15-24.
  • 33
    Blom M, Dawidson I, Angmar-Mansson B. The effect of acupuncture on salivary flow rates in patients with xerostomia. Oral Surg Oral Med Oral Pathol. 1992; 73: 293-298.
  • 34
    Blom M, Lundeberg T, Dawidson I, Angmar-Mansson B. Effects on local blood flux of acupuncture stimulation used to treat xerostomia in patients suffering from Sjogren's syndrome. J Oral Rehabil. 1993; 20: 541-548.
  • 35
    Blom M, Dawidson I, Fernberg JO, Johnson G, Angmar-Mansson B. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol. 1996; 32B: 182-190.
  • 36
    Dawidson I, Blom M, Lundeberg T, Angmar-Mansson B. The influence of acupuncture on salivary flow rates in healthy subjects. J Oral Rehabil. 1997; 24: 204-208.
  • 37
    Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. The influence of sensory stimulation (acupuncture) on the release of neuropeptides in the saliva of healthy subjects. Life Sci. 1998; 63: 659-674.
  • 38
    Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides. 1998; 32: 543-548.
  • 39
    Dawidson I, Angmar-Mansson B, Blom M, Theodorsson E, Lundeberg T. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides. 1999; 33: 244-250.
  • 40
    Johnstone PA, Peng YP, May BC, Inouye WS, Niemtzow RC. Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies. Int J Radiat Oncol Biol Phys. 2001; 50: 353-357.
  • 41
    Johnstone PA, Niemtzow RC, Riffenburgh RH. Acupuncture for xerostomia: clinical update. Cancer. 2002; 94: 1151-1156.
  • 42
    Johnstone PA, Polston GR, Niemtzow RC, Martin PJ. Integration of acupuncture into the oncology clinic. Palliat Med. 2002; 16: 235-239.
  • 43
    Cho JH, Chung WK, Kang W, Choi SM, Cho CK, Son CG. Manual acupuncture improved quality of life in cancer patients with radiation-induced xerostomia. J Altern Complement Med. 2008; 14: 523-526.
  • 44
    Deng L, Gan Y, He S, et al. Chinese Acupuncture and Moxibustion. Beijing, China: Foreign Languages Press; 1997.
  • 45
    Deadman P, Al-Khafaji M, Baker K. A Manual of Acupuncture. East Sussex, England: Journal of Chinese Medicine Publications; 1999.
  • 46
    Helms JM. Acupuncture Energetics: A Clinical Approach for Physicians. Berkeley, CA: Medical Acupuncture Publishers; 1997.
  • 47
    Rosenthal DI, Mendoza TR, Chambers MS, et al. Measuring head and neck cancer symptom burden: the development and validation of the M. D Anderson symptom inventory, head and neck module. Head Neck. 2007; 29: 923-931.
  • 48
    Littell R, Milliken G, Stroup W, Wolfinger R, Schabenberger O. SAS for Mixed Models. 2nd ed. Cary, NC: SAS Institute; 2006.
  • 49
    Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008; 8: 37.